FDA issues warning letter on unapproved stem cell product, Atcell

The FDA has posted a warning letter to American CryoStem Corporation and its chairman/chief executive officer, John S. Arnone, for marketing an adipose derived stem cell product without approval and for significant deviations from cGMP requirements Read more

8 Jan 2018 13:11 News